Live from the NIH registry
Studies recruiting near Allentown right now
Top 25 of 222 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Medtronic
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
St. Luke's University Health Network — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Nectero Medical, Inc.
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
St Luke's University Health, Sacred Heart Campus — Allentown, Pennsylvania (1.1 mi)
· Sponsor: GT Medical Technologies, Inc.
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2
Interventional 40 participants sought
Alliance Cancer Specialists, PC — Doylestown, Pennsylvania (26.8 mi)
· Sponsor: Faeth Therapeutics
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Endometrial Cancer, Endometrioid Adenocarcinoma
N/A
Observational 1,715 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Refractory Differentiated Thyroid Gland Carcinoma
Phase 3
Interventional 264 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing
Wound
N/A
Interventional 90 participants sought
St. Luke's University Hospital — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Solventum US LLC
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Phase 3
Interventional 1,280 participants sought
Lehigh Valley Hospital — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Novo Nordisk A/S
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Lehigh Center for Clinical Research — Allentown, Pennsylvania (1.1 mi)
· Sponsor: TriGemX Bio, Inc.
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Melanoma Stage IIIB, Melanoma Stage IIIC
Phase 3
Interventional 186 participants sought
St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd. — Easton, Pennsylvania (14.8 mi)
· Sponsor: Philogen S.p.A.
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
Phase 1, Phase 2
Interventional 340 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Inhibrx Biosciences, Inc
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.
Arthritis, Unstable Radial Head
N/A
Interventional 84 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Aptis Medical
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Mid Atlantic Retina (Site 050) — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: EyeBiotech Ltd.
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Saint Luke's Cancer Center - Allentown — Allentown, Pennsylvania (1.1 mi)
· Sponsor: NRG Oncology
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Alliance Cancer Specialists, PC — Sellersville, Pennsylvania (19.0 mi)
· Sponsor: Pfizer
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: TG Therapeutics, Inc.
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Generalized Anxiety Disorder
Phase 2
Interventional 705 participants sought
Lehigh Center for Clinical Research LLC — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Northeast Clinical Research Center — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Boehringer Ingelheim
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Acute Leukemia, Newly Diagnosed
N/A
Observational 1,365 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
St. Luke's University Health Network - Allentown Cancer Center — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: SWOG Cancer Research Network